NCT07033091 2026-02-13
Prevalence of Human Papillomavirus (HPV) in a Healthy Population: A Feasibility Study of Oropharyngeal Cancer Screening
The Institute of Molecular and Translational Medicine, Czech Republic
Phase NA Recruiting
Clinical Trials
8 trialsNCT06129253 2025-07-16
HPV
International Vaccine Institute
Recruiting
NCT03542227 2022-11-08
ABSOP-FollowUp
Universiteit Antwerpen
Completed
NCT04391647 2021-09-29
HPV-VACPLUS
Universiteit Antwerpen
Completed
NCT00947115 2020-10-30
Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects
GlaxoSmithKline
Phase 3 Completed
NCT02714114 2017-06-15
AB-SOP
Universiteit Antwerpen
Completed
NCT00518336 2016-12-09
Follow-up Study to Evaluate the Long-term Efficacy of the HPV Vaccine (580299) in Healthy Young Adult Women in Brazil
GlaxoSmithKline
Phase 2 Completed
NCT02100618 2015-07-20
Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study
GlaxoSmithKline
Phase 3 Withdrawn